Fairewinds Energy Education organization has released new statistics that confirm the direct link between the Fukushima nuclear disaster and the growing number of cancer’s in Japan that have tripled since the meltdown.
Chief Engineer, Arnie Gundersen, concludes that heavy radioactive discharges will be the cause of enormous spikes of cancer in Japan.
Based upon data from Japanese medical professionals and utility owner of the meltdown site, Tokyo Electric Power Company (TEPCO), Arnie concludes that heavy radioactive discharges will be the cause of enormous spikes in cancer in Japan.
TEPCO’s press release confirms the leukemia diagnosis for a TEPCO worker due to his ongoing exposure during the last four years to radiation from the Fukushima Daiichi triple meltdown. Sadly, during the early months of the Fukushima Daiichi emergency, most TEPCO workers did not wear the required dosimeters required to measure each employee’s exposure to radiation, which has made accurate assessment of the radiation doses received by TEPCO employees impossible.
The second report, provided by esteemed Japanese medical professionals, reveals that the incidence of thyroid cancer is approximately 230 times higher than normal in the Fukushima Prefecture. This disturbing number for the people of Japan is solely due to the Fukushima Daiichi disaster and the ongoing radioactivity emanating from the decimated nuclear site.
In this video, Arnie recounts his presentation from 2013 at the New York Academy of Medicine where he forecast continuous radiation releases from the Fukushima Daiichi nuclear plant, and also the devastating health effects for the Japanese people, despite the chronically underestimated radiation exposure levels propagated by the International Atomic Energy Agency, and the Japanese government.
Latest posts by Sean Adl-Tabatabai (see all)
- Mark Zuckerberg Quietly Sells His Facebook Stock - March 21, 2018
- CIA Ramps Up Afghan Heroin Smuggling To Fund Wars - March 21, 2018
- Study: Link Found Between Vaccines And Autoimmune Disorders - March 21, 2018